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Sara Darakhshan1, Ali Bidmeshki Pour1* and Ali Ghanbari2*Correction
After publication of this work [1], we noted that we in-
advertently failed to include the complete list of all coau-
thors. The full list of authors has now been added and
authors’ contributions have been updated.
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